Researchers at the Technion – Israel Institute of Technology, the Rambam Healthcare Campus (Rambam Medical Center), and colleagues at the McEwen Stem Cell Institute at the University Health Network in Toronto, Canada have succeeded in producing 3D engineered cardiac tissues from embedded chamber-specific heart cells (atrial and ventricular cells) derived from human stem cells.
The tissues, which simulate heart tissues of the atrium (auricle, or the upper chamber of the heart through which blood enters the ventricles) or the ventricles, will serve in the near future for personalizing medications for cardiac patients and developing new drugs to treat them. In the more distant future, the technology is expected to be utilized in the production of implants for damaged areas in the auricles and ventricles.
Medical start-up Nanosynex was founded by CEO Diane Abensur and VP marketing and business development Michelle Heymann, who met when they were studying for MBAs at the Technion. Both had recently immigrated to Israel; Abensur from France and Heymann from Brazil.
Based on findings by renowned Technion-Israel Institute of Technology cell researcher Prof. Shulamit Levenberg, Nanosynex has developed a method of precisely adapting antibiotics to infections. The objective is to implement more effective and faster treatment without encouraging the resistance of bacteria to the most widely used antibiotics.
A new technology developed by CAPS Medical, an Or Yehuda based start-up, has innovated Cold Atmospheric Plasma (CAP) technology, usually used to treat superficial solid tumors, to now target solid, internal organ tumors. In collaboration with the Technion-Israel Institute of Technology and the Rambam Health Care Campus in Haifa, CAPS Medical has created device small enough to administer the treatment on solid tumors inside the body.
CEO, Ilan Uchitel, said “[We are] progressing with our research and development to develop the next generation of our device. We should be ready for commercialization of the treatment by the end of 2022.”
Quantum Computing is the future of computing – providing unmatched efficiency at analyzing data – and Israel needs to increase investment to ensure the country’s position as a leader in the field. These were the findings of Israel’s National Advisory Committee for Quantum Science and Technology, led by Technion President and Professor Uri Sivan.
Professor Sivan is a member of the Technion Faculty of Physics, and is the founding director of the Russell Berrie Nanotechnology Institute, which he headed between 2005 and 2010. The findings of the committee were the guiding force behind the 2018 decision by the Israel Defense Ministry and Israel Science Foundation to earmark $27 million to research quantum technologies.
Faculty/Degree: MsC, Faculty of Chemical Engineering
Current Location: Vancouver, BC
Professional Highlights: Vice President, International Sales & Marketing for Nova Chemicals in Switzerland
Q & A
Why did you choose to attend the Technion?
I received my undergraduate degree in Chemical Engineering in Romania. When I immigrated to Israel, I chose to attend the Technion both because it was in line with my background and because I knew that it offered a very high level of education.
What were some of the highlights of your Technion education?
I came to Technion for my Master’s degree, and it was an amazing experience - especially for a newcomer to the country. After a year my Hebrew improved a lot and I enjoyed the life of a student in Israel at Technion – both the learning opportunities and the vibrant campus life. The education and the professors were incredible, one of my professors later became the President of the Technion. I also greatly enjoyed working with students in the polymer science lab as a teaching assistant.
How has your Technion education and experience prepared you for your career and contributed to your professional success?
Graduating from the Technion gave me connections, and confidence in myself. I knew so much of the industry because so many of Israel’s engineers were educated at the Technion. Many kibbutzim had plastics factory, I knew the entire network, and visited almost every plastics factory in Israel. I had many job opportunities and when I worked internationally, the Technion’s reputation and my own level of knowledge gave me confidence that I was an expert in my field.
What makes you most proud to be a Technion Alumnus?
Technion is one of the best contributors to Israel’s success in every possible industry – the contribution to start up nation is huge. As a graduate, you have a sense of pride and confidence that you carry with you for life.
What is your message to anyone giving back to Technion or considering doing so?
Anyone who has benefitted from the Technion should consider it a top priority to give back. When you give to Technion you help further the success of the state of Israel. When I meet a young person, I always tell them about the Technion. I am proud to be a Technion Canada Board Member and I am working out West to raise awareness and meet alumni.
During his recent trip to Israel to mark United Nations Holocaust Remembrance Day, Prince Charles met with Technion Professor Hossam Haick to discuss the SniffPhone. The brief meeting took place during an event at the residence of the Israeli President.
SniffPhone combines nanotechnology, biochemistry, materials engineering, process engineering, biomedical engineering, electrical engineering, and medicine in a miniaturized system that relies on an artificially intelligent nanoarray for inexpensive, fast, non-invasive detection of diseases via exhaled breath. Prof. Haick is the F.M.W. Academic Chair of the Technion’s Wolfson Faculty of Chemical Engineering. He is also a faculty member in the Russell Berrie Nanotechnology Institute, and an affiliated engineering faculty member in the Technion Integrated Cancer Center.
“Imagination is more important than knowledge. Knowledge is limited. Imagination encircles the world.” – Albert Einstein, Founder of the first Technion Society.
When knowledge meets imagination, innovation is born. After all, how can one create something new without thinking outside of the box?
The Technion is know world-wide for its cutting edge innovation, so it’s only fitting that we celebrate some of Technion’s most exciting inventors in honour of National Inventor’s Day on February 11th.
Prof. Hossam Haick of Technion’s Wolfson Faculty of Chemical Engineering presents SNIFFPHONE, a Horizon 2020 EU project that has harnessed nanotechnology, (bio)chemistry, materials engineering, process engineering, biomedical engineering, electrical engineering, and medicine to develop and test a miniaturized system that relies on an artificially intelligent nano-array for an inexpensive, fast, non-invasive detection of gastric cancer via exhaled breath.
The USB key
Technion alumnus Dov Moran is an entrepreneur and investor. But what he is best known for is his invention which changed the world, the USB flash drive. With this invention, massive amounts of information can be transported in your pocket from one computer to the next. Used by everyone from CEOs to DJs, this little stick has a huge impact on the way we move data.
Kobi Vortman graduated from Technion with a vision. His work led him to create InSightec, which destroys tumors by using ultrasound. No incisions means no scars, a reduced risk of infection and less time for post-operative healing. This innovative biotechnology “cooks” tumors to death without harming the body.
Sealantis develops medical device products, based on a proprietary platform of alga-mimetic tissue adhesives, for a variety of applications in surgical adhesion. The company was established through the AMIT Institute at the Technion, under the leadership of Prof. Havazelet Bianco-Peled, a world-renowned expert in biomedical polymers, from the Faculty of Chemical Engineering at the Technion. The company’s present focus is on surgical seals designed to stop bleeding, prevent leakage of digestive tract contents into the abdominal cavity, prevent leakage of spinal fluid, and a variety of other applications.
40 years ago, Profs. Abraham Lempel and Jacob Ziv of Technion’s Faculty of Computer Science started something remarkable. They discovered the math behind the internet and the legendary Lempel-Ziv Algorithm was born. Now known as the international standard for data compression, their invention is the reason you’re able to read this article right now.
Prof. Shulamit Levenberg, Dean of Technion’s Faculty of Biomedical Engineering and Prof. Lior Gepstein, of Technion’s Faculty of Medicine, make quite the team. This dynamic duo is changing the field of regenerative medicine. Using human embryonic stem cells, they can create artificial tissue to create a new heart muscle with its own blood supply. Through new and innovative 3D printing technology, it is now possible to replace cardiac tissue damaged by the patient’s heart disease.
Professor Alon Wolf is a leading robotics researcher and also serves as Vice President, External Relations & Resource Development at the Technion. His invention, the Snake Robot, is a snake-like device controlled by surgeons that enters a patient’s body without incision to locate the area requiring treatment. Thanks to this invention, many patients can avoid complications such as trauma, risk of infection and decreases rates of hospitalization – an important advancement in the field of surgical medicine.
Dr. Assaf Glazer completed his Ph.D. at the Technion, specialized in the fields of machine learning and computer vision, and later worked as a post-doctorate in the Runway Program at the Jacobs Institute at Cornell-Tech. Today, Glazer is the CEO and Founder of Nanit – a company creating smart baby monitors that use machine learning algorithms to provide sleep insights through first-of-its-kind camera vision. Nanit even made CNBC’s most promising startups list!
Prof. Yuval Shaked has quite a few titles under his belt, as well as grants, awards and research papers. Currently, he is the head of the Technion’s Integrated Cancer Center and has been leading a research project which led to creation of Oncohost. Oncohost is a personalized cancer treatment which uses machine learning to characterize, analyze and predict a patient’s response to treatment.
Technion’s students, teachers and alumni come together every day to deliver innovations and inventions that change our world. They lead by example, teaching us that when a problem arises you need to think creatively and outside the box to solve it.
Contribute to tomorrow’s innovation and help aspiring inventors make our world a better place. Direct your support to Entrepreneurship & Innovation through the Technion Fund.
Technion Canada is a registered Canadian charity. Federal Charitable Number: BN11883 6519 RR0001 All charitable donations to Technion Canada are entitled to an official Canadian tax receipt.